DK1952805T3 - Tablet indeholdende hydrogenerede phospholipider - Google Patents

Tablet indeholdende hydrogenerede phospholipider

Info

Publication number
DK1952805T3
DK1952805T3 DK08100830.2T DK08100830T DK1952805T3 DK 1952805 T3 DK1952805 T3 DK 1952805T3 DK 08100830 T DK08100830 T DK 08100830T DK 1952805 T3 DK1952805 T3 DK 1952805T3
Authority
DK
Denmark
Prior art keywords
tablet containing
containing hydrogenated
hydrogenated phospholipids
phospholipids
tablet
Prior art date
Application number
DK08100830.2T
Other languages
English (en)
Inventor
Ulrich Massing
Annette Bauer-Brandl
Original Assignee
Ktb Tumorforschungs Gmbh
Univ Tromsoe
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ktb Tumorforschungs Gmbh, Univ Tromsoe filed Critical Ktb Tumorforschungs Gmbh
Application granted granted Critical
Publication of DK1952805T3 publication Critical patent/DK1952805T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
DK08100830.2T 2007-01-23 2008-01-23 Tablet indeholdende hydrogenerede phospholipider DK1952805T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07101047A EP1952803A1 (en) 2007-01-23 2007-01-23 Solid pharmaceutical dosage form containing hydrogenated phospholipids

Publications (1)

Publication Number Publication Date
DK1952805T3 true DK1952805T3 (da) 2012-12-17

Family

ID=38066929

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08100830.2T DK1952805T3 (da) 2007-01-23 2008-01-23 Tablet indeholdende hydrogenerede phospholipider

Country Status (4)

Country Link
US (1) US20080187583A1 (da)
EP (2) EP1952803A1 (da)
DK (1) DK1952805T3 (da)
SI (1) SI1952805T1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1745788A1 (de) * 2005-07-22 2007-01-24 KTB Tumorforschungsgesellschaft mbH Acylglycerophospholipide zur Behandlung von Krebs und Tumorkachexie
US9907323B2 (en) 2015-09-25 2018-03-06 Mead Johnson Nutrition Co. Infant formula tablets
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
US20220249375A1 (en) * 2019-06-28 2022-08-11 Jiangsu Hengrui Medicine Co., Ltd. Sustained-release lipid composition and preparation method therefor

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2057695A (en) * 1933-12-13 1936-10-20 American Lecithin Co Method for the production of vegetable phosphatide preparations
JPS5457820A (en) 1977-10-17 1979-05-10 Ricoh Co Ltd Pre-processing system for coding of pattern information
US4374082A (en) 1981-08-18 1983-02-15 Richard Hochschild Method for making a pharmaceutical and/or nutritional dosage form
US4882167A (en) 1983-05-31 1989-11-21 Jang Choong Gook Dry direct compression compositions for controlled release dosage forms
DE3613799C1 (de) * 1986-04-24 1987-09-03 Nattermann A & Cie Verwendung von Glycofurol zum Verfluessigen von Arzneimittelzubereitungen fuer das Abfuellen in Weichgelatinekapseln
JPS6348226A (ja) * 1986-08-14 1988-02-29 Ono Pharmaceut Co Ltd 徐放性を有する経口投与用固形製剤
US4762658A (en) 1986-10-08 1988-08-09 Central Soya Company, Inc. Method of tableting of de-oiled phosphatides (lecithin)
US5376381A (en) * 1988-02-25 1994-12-27 The Liposome Company, Inc. Integrity protected gelatin
GB2305604B (en) 1995-09-29 1999-06-23 Quest Vitamins Ltd Carrier base material
IL117773A (en) 1996-04-02 2000-10-31 Pharmos Ltd Solid lipid compositions of coenzyme Q10 for enhanced oral bioavailability
BR9813808A (pt) 1997-12-19 2002-05-28 Smithkline Beecham Corp Processo para produção de comprimidos para dispersão na mordida
FR2775188B1 (fr) * 1998-02-23 2001-03-09 Lipha Forme galenique a liberation immediate ou liberation prolongee administrable par voie orale comprenant un agent promoteur d'absorption et utilisation de cet agent promoteur d'absorption
CA2352178A1 (en) 1998-12-08 2000-06-15 Mathew Louis Steven Leigh Phospholipid compositions
US20030161879A1 (en) 1999-06-29 2003-08-28 Shinji Ohmori Tablets quickly disintegrating in mouth
JP2003507410A (ja) 1999-08-25 2003-02-25 アドバンスト インハレーション リサーチ，インコーポレイテッド 乾燥粉末製剤からの放出調節
US8586094B2 (en) 2000-09-20 2013-11-19 Jagotec Ag Coated tablets
FR2814366A1 (fr) * 2000-09-22 2002-03-29 Rhodia Chimie Sa Procede de granulation de matieres actives par extrusion basse pression pour l'obtention de granules directement compressibles
AU2001292287A1 (en) * 2000-10-26 2002-05-06 Senju Pharmaceutical Co. Ltd. Drug composition comprising dipeptydyl aldehyde derivative
WO2002096354A2 (en) 2001-05-29 2002-12-05 Tap Pharmaceutical Products Inc. Enhancement of oral bioavailability of non-emulsified formulation of prodrug esters with lecithin
CA2495899A1 (en) 2002-08-15 2004-03-18 Yunqing Liu Solid nano pharmaceutical formulation and preparation method thereof
DE10340741A1 (de) 2003-09-04 2005-03-31 Degussa Food Ingredients Gmbh Formulierung auf Phospholipidbasis
US7658944B2 (en) * 2003-10-10 2010-02-09 Lifecycle Pharma A/S Solid dosage form comprising a fibrate
US20060182803A1 (en) * 2005-02-17 2006-08-17 Standard Chem. & Pharm. Co., Ltd. Oral sustained-release pharmaceutical composition of indapamide, production and use thereof
EP1745788A1 (de) 2005-07-22 2007-01-24 KTB Tumorforschungsgesellschaft mbH Acylglycerophospholipide zur Behandlung von Krebs und Tumorkachexie
RU2009121838A (ru) * 2006-11-10 2010-12-20 Альфаптозе ГмбХ (DE) Пероральная лекарственая форма, содержащая соединения тризамещенного глицерина

Also Published As

Publication number Publication date
SI1952805T1 (sl) 2013-07-31
EP1952805B1 (en) 2012-08-29
EP1952803A1 (en) 2008-08-06
US20080187583A1 (en) 2008-08-07
EP1952805A1 (en) 2008-08-06

Similar Documents

Publication Publication Date Title
LTPA2020003I1 (lt) Dvisluoksnės tabletės formuluotės
LTC2140867I2 (lt) Farmacinė kompozicija
BRPI0721651A2 (pt) Composição farmacêutica
DK2151438T3 (da) Lægemiddel indeholdende PPAR-Deltaagonist
BRPI0920521A2 (pt) combinação farmacêutica
BRPI0810250A2 (pt) Compostos inéditos
DK2114143T3 (da) Flydende sulfonylurea-herbicidformuleringer
DE602008003596D1 (de) Stereoskopische Anzeigevorrichtung
BRPI0818079A2 (pt) composição de lipideo
DK2120884T3 (da) Farmaceutisk sammensætning
BRPI0821735A2 (pt) Fabricação de tablete
AT504327B8 (de) Tablettenabfüllvorrichtung
DK2966175T3 (da) Farmaceutiske sammensætninger indeholdende cortexolon-17-alpha-propionat
BRPI0818598A2 (pt) agentes terapêuticos - 802
FI20075825A0 (fi) Jakelulaite
DK1952805T3 (da) Tablet indeholdende hydrogenerede phospholipider
BRPI0819359A2 (pt) Unidade de embalagem
DE602007009636D1 (de) Sektionaltor
FR2926088B1 (fr) Tablette detergente multicouche
DE112006004052A5 (de) Anzeigegerät
FR2924587B1 (fr) Presentoir
BRPI0820839A2 (pt) Composição farmacêutica
AT505785A3 (de) Dispenser
FI20075678A0 (fi) Monitelakalanteri
SE0702492L (sv) Stativ